>
pdufa.bio

MR-100A-01

Updated ยทnext FDA decision on the calendar

MR-100A-01 is a Viatris Inc. program in Contraception. Every date links its source.

VTRS catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Indication under review: Contraception. Sponsor: Viatris Inc. (VTRS). Market-cap tier at the time we tracked it: Large. We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

PDUFA · Jul 30, 2026VTRS

Questions

When is MR-100A-01's next FDA decision or readout?

No upcoming catalyst is on our calendar for MR-100A-01; no FDA decisions are on record below.

What happened at MR-100A-01's most recent FDA decision?

No FDA decision for MR-100A-01 is in our archive yet.

What is MR-100A-01 used for?

In our records MR-100A-01 is under review or in development for Contraception.

Who makes MR-100A-01?

Viatris Inc. (VTRS).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.